نتایج جستجو برای: pharmacovigilance pv
تعداد نتایج: 26071 فیلتر نتایج به سال:
Background: Pharmacovigilance of biological medicines is crucial because it ensures that meet the World Health Organization (WHO) standards. In Zambia, there little information on healthcare professionals’ familiarity, knowledge and practices pharmacovigilance biosimilar medicines. Therefore, this study investigated knowledge, related to (PV) at selected hospitals in Lusaka, Zambia. Methods: Th...
INTRODUCTION Pharmacovigilance (PV) is designed to monitor drugs continuously after their commercialization, assessing and improving their safety profile. The main objective is to increase the spontaneous reporting of adverse drug reactions (ADRs), in order to have a wide variety of information. The Italian Drug Agency (Agenzia Italiana del Farmaco [AIFA]) is financing several projects to incre...
Drug name recognition (DNR) is an essential step in the Pharmacovigilance (PV) pipeline. DNR aims to find drug name mentions in unstructured biomedical texts and classify them into predefined categories. State-of-the-art DNR approaches heavily rely on hand-crafted features and domain-specific resources which are difficult to collect and tune. For this reason, this paper investigates the effecti...
Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other problems related to medical products after they have been licensed for marketing. The purpose of PV is to advance the safe use of marketed medical products. Regulatory agencies and license holders collaborate to collect data reported by health car...
INTRODUCTION In 2010, WHO recommended a new first-line treatment for visceral leishmaniasis (VL) in Eastern Africa. The new treatment, a combination of intravenous (IV) or intramuscular (IM) sodium stibogluconate (SSG) and IM paromomycin (PM) was an improvement over SSG monotherapy, the previous first-line VL treatment in the region. To monitor the new treatment's safety and effectiveness in ro...
Background Pharmacovigilance (PV) data are crucial for ensuring safety and effectiveness of medicines after drugs have been granted marketing approval. This paper describes the PV systems of India, Uganda and South Africa based on literature and Key Informant (KI) interviews and compares them with the World Health Organization’s (WHO’s) minimum PV requirements for a Functional National PV Syste...
The Pharmacoviligance section in this issue opens the door to a very interesting topic: ecopharmacovigilance. This article is result of collaboration among volunteers EMWA’s Pharma covigilance Special Interest Group (PV SIG) and Ecopharmacovigilance SIG at International Society Pharmacovigilance (ISoP). authors have realised that there an urgent need measure impact understand current picture pr...
Under-reporting of ADR may be associated with poor knowledge, attitudes and practices to pharmacovigilance. This study evaluated knowledge, attitudes and practices of healthcare professionals about ADR monitoring and reporting following interventions. This longitudinal study included 36 healthcare professionals participating in ART program in a tertiary hospital. Interventions included group tr...
Background and Objectives: Pharmacovigilance is central to the control of the menace of adverse drugs reactions. Despite the fact that development of policy and practice framework to improve patients’ safety partly rely on availability of authentic data on pharmacovigilance activities, knowledge about pharmacovigilance activities among healthcare professionals in Nigeria is limited. To help fil...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید